John Lechleiter has been named the new CEO of Eli Lilly, reports the Wall Street Journal, and Derek Lowe thinks that's unusual (but still cool) because Lechleiter's a researcher who worked his way up from the bench to management. Lowe ponders why that doesn't happen more often in pharma. One reason is that a lot of scientists don't want to be managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.